EUVIMED · CrossrefZeitschrift
Expert Opinion on Drug Metabolism & Toxicology
ISSN 1742-5255 · Informa UK Limited
Neueste Artikel
Understanding pharmacokinetics of novel prolonged release dienogest 2 mg / ethinyl-estradiol 0.02 mg oral contraceptive formulation: clinical applications
Population pharmacokinetic models for unbound mycophenolic acid
Maternal–placental–fetal physiologically based pharmacokinetic modeling: current approaches and future perspectives
Vepdegestrant (ARV-471): pharmacokinetics, drug metabolism and clinical translation of an oral ERα-targeting PROTAC
An update on beta-lactam–beta-lactamase inhibitor combinations for the treatment of carbapenem-resistant Gram-negative pathogens
Microbiome-driven PKs: redefining drug metabolism beyond host enzymes
The clinical implication of inflammation-driven regulation of drug-metabolizing enzymes
Pharmacokinetic drug evaluation of co-packaged sulbactam for injection and durlobactam for injection for the treatment of Acinetobacter baumannii-calcoaceticus complex in HABP/VABP
Suboptimal concentrations of isavuconazole in critically ill patients treated for mold infections: a population pharmacokinetic analysis
Language models for drug–drug interactions: current applications, pitfalls, and future directions
Comparison of ADMET profile between thiosemicarbazide and semicarbazide derivatives regarding anticancer properties
Pharmacokinetic evaluation of concizumab for the treatment of hemophilia
Pharmacokinetic and pharmacodynamic alterations in older people: what we know so far
Drug-drug interactions in metastatic hormone-sensitive prostate cancer (mHSPC): practical considerations for treating men with androgen receptor pathway inhibitors and common medications in this stage
The influence of female sex and estrogens on drug pharmacokinetics: what is the evidence?
Epigenetics is involved in the pleiotropic effects of statins
DILI prediction in drug development: present and future
Hormones, microbes, and PrEP drugs in the female genital tract
A comprehensive review of the efficacy and safety of ertugliflozin
Mechanisms of altered hepatic drug disposition during pregnancy: small molecules
Immune-mediated liver injury caused by immune checkpoint inhibitors exhibits distinct clinical features that differ from autoimmune hepatitis
The oral GnRH antagonists, a new class of drugs in gynecology: from pharmacokinetics to possible clinical applications
Pharmacokinetics and pharmacodynamics of angiogenesis inhibitors used to treat cervical cancer: current and future
Rezafungin acetate for the treatment of candidemia and invasive candidiasis: a pharmacokinetic evaluation
Cefepime/Enmetazobactam: a microbiological, pharmacokinetic, pharmacodynamic, and clinical evaluation
Drug interactions in cardiology: focus on statins and their combination with other lipid-lowering drugs
Pharmacokinetics of aspirin: evaluating shortcomings in the literature
In-depth mechanistic analysis including high-throughput RNA sequencing in the prediction of functional and structural cardiotoxicants using hiPSC cardiomyocytes
Where developmental toxicity meets explainable artificial intelligence: state-of-the-art and perspectives
Beyond the hype and toward application: liver complex in vitro models in preclinical drug safety
EUVIMED